Acute Liver failure
Wahid Altaf
Case…Thursday evening call from AnE
registrar
 Mr C.E. 56 Year old male.
 Presenting complaint of
Jaundice
Confusion
Feeling unwell
 Background history, liver transplant 8yrs ago with
normal liver functions untill 20 days back.
Further questioning
 Hypotension
 Tachycardia
 Vasodilatory shock
 Severe Compensated Metabolic acidosis Ph 7.37 HCO3 14
lactate 8
 Blood Glucose 2.5
 Deranged Liver functions.( Bilirubin 116, ALP 357,
GGT 103,AST 1241,ALT 873).
Definition of Liver failure
“The abrupt loss of hepatocellular function in a patient
with previously normal liver function, the expression of
which includes coagulopathy and encephalopathy.”
AASLD…“Evidence of a coagulation abnormality
(INR>1.5) and mental alteration (encephalopathy) in a
patient without pre-existing cirrhosis and with an illness
of <26wks duration”
Encephalopathy
Classification
Parradox
 Rapid onset ALF ----> higher risk of cerebral
edema but better prognosis for recovery
 Classic example: Paracetamol OD
 Slow onset ALF -----> lower risk of cerebral
edema, higher risk of portal hypertensive
problems (e.g. ascites, variceal bleeding),
and ultimately poorer prognosis (w/o
transplant)
 Classic example: NANB hepatitis
Etiology
Common drugs causing ALF
 Isoniazid
 Sulfur Antibiotics
 Nitrofurantoin
 Azole antifungals
 Antiepileptics- Phenytoin, sodium valproate.
 Herbals-ex kava kava,ma huang,comfrey.
 Ibuprofen
 Statins
Prognosis…family
Poor prognosis
 Phone a friend, call
Your consultant
Don’t hesitate to call
St. Vincent University Hospital.
Mortality
 Hospital survival
Mid 1970”s ….. 17%
Mid 2000”s …... 62%
Pathophysiology
 Death of a mass of hepatocytes.
 Loss of vital synthetic and metabolic hepatic functions.
 Sterile inflammatory condition leading to SIRS.
 Aim of management is to halt progression from hepatic
impairment to MODS.
Investigations
 ALT, AST, ALP,GGT.
 Bilirubin, Ammonia, Lactate.
 Blood glucose, Coags: PT, aPTT, INR, Albumin.
 Electrolytes, Mg, Phos.
 Arterial blood gas
 FBC with differential.
 Drug screening, paracetamol levels
Investigations.
 If under 35 years of age
Ceruloplasmin, Serum & urine copper
 Anti HAV IgM
 Anti HBc IgM/ Anti HBsAg
 Anti-HCV
 Pregnancy test
 Autoimmune markers – ANA, ASMA, Ig levels
 HIV status
 Amylase & lipase
Invstg
 Diagnostic imaging
 Liver biopsy
Imaging
 Microbiology : Strep parasanguinus and candida.
Ammonia levels
 >75 mcg/l …Encephalopathy
 >200 mcg/l…Cerebral oedema and raised ICP.
Cause-Specific therapy
Cause-specific therapy
N-Acetylcysetine
•May improve circulatory function and oxygen delivery
•No improvement in overall survival but significant improvement in
transplant-free survival with encephalopathy grade 1-2.
Time to NAC administration important
Time in hrs Mortality (%)
<12 0.4
>12 6
>24 13
>48 19
•Now generally recommended for all patients with ALF
When to pick up the phone in
paracetamol overdose
 D2-
 pH <7.3
 INR>3
 Cr >200
 Hypoglycaemia
 D3-
 HE
 Cr>200
 INR >4.5
 D4-
 Any rise in INR
 Cr >250
 HE
Good ICU housekeeping
 Stress ulcer prophylaxis
 No DVT prophylaxis
 Feeding
 Blood glucose management
 Electrolytes like phosphate and magnesium.
Lines
 Ultrasound guided
 No correction of coagulopathy
 Arterial line
 Central line
 Vascath
Severe Vasodilatory shock
 Optimise cardiac filling pressures
–Haemodynamics can be challenging to determine given
the disruptive effects of liver failure on the vasculature
 Saline challenge, albumin.
 Vasopressors
Vasopressors
 Nor-Adrenaline
 Terlipressin
 Vasopressin..no evidence of splanchnic ischemia.
Sedation
 Avoid if possible
 Propofol/Remifentanyl is reasonable
Pulmonary considerations
 Airway
–Elective intubation
–Elective intubation once in grade 3 encephalopathy
 Rapid intubation technique
–Avoid spikes in ICP or decreased CPP
 Pneumonia
–Commonest site of sepsis
 Acute lung injury/ARDS
–In one third of patients
Renal failure
 Renal failure in 50%
 Particularly common with paracetamol overdose
–Liver and renal metabolites
Management
 Volume control
 Maintenance of blood pressure
 Prevention/treatment of sepsis
 Judicious selection of drugs
 Early use of renal replacement therapy
–Before fluid problems aggravate cardiovascular status and
ICP
–Sodium management
–Better ammonia level management
Complications of acute liver failure
and management
Management of complications
 Cerebral edema
 Sepsis
 Coagulopathy
Cerebral oedema
Predictors of cerebral edema
•Rapid onset ALF
―Rapid accumulation of glutamine overwhelms astrocytes'
ability to exclude organic osmolytes
•Grade 3-4 encephalopathy
―High ammonia concentrations
•Infection and/or SIRS
―Case for prophylactic antibiotics
•Vasopressor therapy
•Renal replacement therapy
Invasive monitoring of ICP
Delaying the onset of raised ICP
Delaying the onset of raised ICP
Delaying the onset of raised ICP
Two principles in management of
cerebral oedema
Raised ICP management
 1st line Mannitol
 2nd line Hyperventillation to PaCO2 25-35mmhg
 3rd line Hypertonic saline, Hypothermia
 4th line Barbiturates, Anticonvulsants
 Other considerations Transplantation, total
hepatectomy.
Infection
•Infection is near-universal
–Failing liver results in failed host defences
–Infection precipitates MOSF, cerebral oedema
–Frequent cause of death
•Organisms
–Bacterial and fungal
–Gram negative organisms (52%) more frequent than
Gram-positive organisms (44%) and Candida Infection
Sites of sepsis
Recommendations
 Minimize invasive procedures, strict asepsis
 Daily chest radiograph and surveillance cultures
 Empiric broad spectrum antibiotics for those patients
at greatest risk:
–Grade 3-4 encephalopathy
–Renal failure
–Any component of SIRS
–Planned transplantation (includes antifungals)
Coagulopathy
 Increased INR present by definition
 Thrombocytopenia present in up to 70%
 TEG is reassuring
Is there bleeding diathesis?
 Significant bleeding is uncommon: 5%
–Anticoagulant proteins decrease in parallel with coagulation
factors
–Spontaneous intracranial haemorrhage is rare
 Less clinically-significant bleeding may occur from several
sites
–Gastric mucosa
–PPIs
 Invasive procedures offer the greatest risk
Correcting coagulopathy before
invasive procedures
 Correction itself carries risks
–Volume overload
–Aggravation of ICP
–Transfusion-related acute lung injury
–Thromboembolism (particularly with recombinant Factor
VIIa)
 Commonly used goal of INR <1.5 untested, lacks scientific
basis
 Correction obscures underlying trends in INR which are
important prognostically.
Correcting coagulopathy before
invasive procedures
 FFP not encouraged except to correct coagulopathy before invasive procedure
–Effect modest, short-lived
–Does not improve survival
 Platelet transfusions
–Rarely necessary
 Recombinant activated Factor VII
–Is effective
–Cost
–Short-lived effect
–Prothrombotic
Other options
 Liver transplant
 MARS.. Extracorporeal support, dialysis against albumin.
 CRRT against albumin.
Liver transplant
Accepted Indications Absolute contraindications
Acute Liver Failure Brainstem herniation
Decompensated cirrhosis with
MELD>15
Severe intracranial hypertention
(ICH>50)
Hepatocellular criteria with Milan
criteria
Advanced cardiopulmonary
disease.Haemodynamic
unstability,requiring high dose
pressors
Hilar cholangiocarcinoma Uncontrolled infection
Hepatopulmonary syndrome Multiorgan failure
Portopulmonary hypertention Current/Recent extrahepatic
malignancy unless tumour
free>2yrs
Primary hyperoxaluria Untrated alcoholism/Drug use
Cystic fibrosis with liver
involvement
Severe uncontrolled mood
disorders
Palliate
 Declined by liver services
 Refractory ICP
 Blown pupils
 Communication skills
 Don’t forget morphine infusion.
In summary
•Causes
•Help
•Bloods
•NAC
•Early lines, don’t be afraid
•Drugs, dialysis
•Raised ICP
•Coagulation
•Manage Infections
•Transplant
•Palliate
Acute liver failure in icu

Acute liver failure in icu

  • 1.
  • 2.
    Case…Thursday evening callfrom AnE registrar  Mr C.E. 56 Year old male.  Presenting complaint of Jaundice Confusion Feeling unwell  Background history, liver transplant 8yrs ago with normal liver functions untill 20 days back.
  • 3.
    Further questioning  Hypotension Tachycardia  Vasodilatory shock  Severe Compensated Metabolic acidosis Ph 7.37 HCO3 14 lactate 8  Blood Glucose 2.5  Deranged Liver functions.( Bilirubin 116, ALP 357, GGT 103,AST 1241,ALT 873).
  • 4.
    Definition of Liverfailure “The abrupt loss of hepatocellular function in a patient with previously normal liver function, the expression of which includes coagulopathy and encephalopathy.” AASLD…“Evidence of a coagulation abnormality (INR>1.5) and mental alteration (encephalopathy) in a patient without pre-existing cirrhosis and with an illness of <26wks duration”
  • 5.
  • 6.
  • 7.
    Parradox  Rapid onsetALF ----> higher risk of cerebral edema but better prognosis for recovery  Classic example: Paracetamol OD  Slow onset ALF -----> lower risk of cerebral edema, higher risk of portal hypertensive problems (e.g. ascites, variceal bleeding), and ultimately poorer prognosis (w/o transplant)  Classic example: NANB hepatitis
  • 8.
  • 9.
    Common drugs causingALF  Isoniazid  Sulfur Antibiotics  Nitrofurantoin  Azole antifungals  Antiepileptics- Phenytoin, sodium valproate.  Herbals-ex kava kava,ma huang,comfrey.  Ibuprofen  Statins
  • 10.
  • 11.
    Poor prognosis  Phonea friend, call Your consultant Don’t hesitate to call St. Vincent University Hospital.
  • 12.
    Mortality  Hospital survival Mid1970”s ….. 17% Mid 2000”s …... 62%
  • 13.
    Pathophysiology  Death ofa mass of hepatocytes.  Loss of vital synthetic and metabolic hepatic functions.  Sterile inflammatory condition leading to SIRS.  Aim of management is to halt progression from hepatic impairment to MODS.
  • 14.
    Investigations  ALT, AST,ALP,GGT.  Bilirubin, Ammonia, Lactate.  Blood glucose, Coags: PT, aPTT, INR, Albumin.  Electrolytes, Mg, Phos.  Arterial blood gas  FBC with differential.  Drug screening, paracetamol levels
  • 15.
    Investigations.  If under35 years of age Ceruloplasmin, Serum & urine copper  Anti HAV IgM  Anti HBc IgM/ Anti HBsAg  Anti-HCV  Pregnancy test  Autoimmune markers – ANA, ASMA, Ig levels  HIV status  Amylase & lipase
  • 16.
  • 17.
    Imaging  Microbiology :Strep parasanguinus and candida.
  • 18.
    Ammonia levels  >75mcg/l …Encephalopathy  >200 mcg/l…Cerebral oedema and raised ICP.
  • 20.
  • 21.
  • 22.
    N-Acetylcysetine •May improve circulatoryfunction and oxygen delivery •No improvement in overall survival but significant improvement in transplant-free survival with encephalopathy grade 1-2. Time to NAC administration important Time in hrs Mortality (%) <12 0.4 >12 6 >24 13 >48 19 •Now generally recommended for all patients with ALF
  • 23.
    When to pickup the phone in paracetamol overdose  D2-  pH <7.3  INR>3  Cr >200  Hypoglycaemia  D3-  HE  Cr>200  INR >4.5  D4-  Any rise in INR  Cr >250  HE
  • 24.
    Good ICU housekeeping Stress ulcer prophylaxis  No DVT prophylaxis  Feeding  Blood glucose management  Electrolytes like phosphate and magnesium.
  • 25.
    Lines  Ultrasound guided No correction of coagulopathy  Arterial line  Central line  Vascath
  • 26.
    Severe Vasodilatory shock Optimise cardiac filling pressures –Haemodynamics can be challenging to determine given the disruptive effects of liver failure on the vasculature  Saline challenge, albumin.  Vasopressors
  • 27.
    Vasopressors  Nor-Adrenaline  Terlipressin Vasopressin..no evidence of splanchnic ischemia.
  • 28.
    Sedation  Avoid ifpossible  Propofol/Remifentanyl is reasonable
  • 29.
    Pulmonary considerations  Airway –Electiveintubation –Elective intubation once in grade 3 encephalopathy  Rapid intubation technique –Avoid spikes in ICP or decreased CPP  Pneumonia –Commonest site of sepsis  Acute lung injury/ARDS –In one third of patients
  • 30.
    Renal failure  Renalfailure in 50%  Particularly common with paracetamol overdose –Liver and renal metabolites
  • 31.
    Management  Volume control Maintenance of blood pressure  Prevention/treatment of sepsis  Judicious selection of drugs  Early use of renal replacement therapy –Before fluid problems aggravate cardiovascular status and ICP –Sodium management –Better ammonia level management
  • 32.
    Complications of acuteliver failure and management
  • 33.
    Management of complications Cerebral edema  Sepsis  Coagulopathy
  • 34.
  • 35.
    Predictors of cerebraledema •Rapid onset ALF ―Rapid accumulation of glutamine overwhelms astrocytes' ability to exclude organic osmolytes •Grade 3-4 encephalopathy ―High ammonia concentrations •Infection and/or SIRS ―Case for prophylactic antibiotics •Vasopressor therapy •Renal replacement therapy
  • 36.
  • 37.
    Delaying the onsetof raised ICP
  • 38.
    Delaying the onsetof raised ICP
  • 39.
    Delaying the onsetof raised ICP
  • 40.
    Two principles inmanagement of cerebral oedema
  • 41.
    Raised ICP management 1st line Mannitol  2nd line Hyperventillation to PaCO2 25-35mmhg  3rd line Hypertonic saline, Hypothermia  4th line Barbiturates, Anticonvulsants  Other considerations Transplantation, total hepatectomy.
  • 42.
    Infection •Infection is near-universal –Failingliver results in failed host defences –Infection precipitates MOSF, cerebral oedema –Frequent cause of death •Organisms –Bacterial and fungal –Gram negative organisms (52%) more frequent than Gram-positive organisms (44%) and Candida Infection
  • 43.
  • 44.
    Recommendations  Minimize invasiveprocedures, strict asepsis  Daily chest radiograph and surveillance cultures  Empiric broad spectrum antibiotics for those patients at greatest risk: –Grade 3-4 encephalopathy –Renal failure –Any component of SIRS –Planned transplantation (includes antifungals)
  • 45.
    Coagulopathy  Increased INRpresent by definition  Thrombocytopenia present in up to 70%  TEG is reassuring
  • 46.
    Is there bleedingdiathesis?  Significant bleeding is uncommon: 5% –Anticoagulant proteins decrease in parallel with coagulation factors –Spontaneous intracranial haemorrhage is rare  Less clinically-significant bleeding may occur from several sites –Gastric mucosa –PPIs  Invasive procedures offer the greatest risk
  • 47.
    Correcting coagulopathy before invasiveprocedures  Correction itself carries risks –Volume overload –Aggravation of ICP –Transfusion-related acute lung injury –Thromboembolism (particularly with recombinant Factor VIIa)  Commonly used goal of INR <1.5 untested, lacks scientific basis  Correction obscures underlying trends in INR which are important prognostically.
  • 48.
    Correcting coagulopathy before invasiveprocedures  FFP not encouraged except to correct coagulopathy before invasive procedure –Effect modest, short-lived –Does not improve survival  Platelet transfusions –Rarely necessary  Recombinant activated Factor VII –Is effective –Cost –Short-lived effect –Prothrombotic
  • 49.
    Other options  Livertransplant  MARS.. Extracorporeal support, dialysis against albumin.  CRRT against albumin.
  • 50.
    Liver transplant Accepted IndicationsAbsolute contraindications Acute Liver Failure Brainstem herniation Decompensated cirrhosis with MELD>15 Severe intracranial hypertention (ICH>50) Hepatocellular criteria with Milan criteria Advanced cardiopulmonary disease.Haemodynamic unstability,requiring high dose pressors Hilar cholangiocarcinoma Uncontrolled infection Hepatopulmonary syndrome Multiorgan failure Portopulmonary hypertention Current/Recent extrahepatic malignancy unless tumour free>2yrs Primary hyperoxaluria Untrated alcoholism/Drug use Cystic fibrosis with liver involvement Severe uncontrolled mood disorders
  • 51.
    Palliate  Declined byliver services  Refractory ICP  Blown pupils  Communication skills  Don’t forget morphine infusion.
  • 52.
    In summary •Causes •Help •Bloods •NAC •Early lines,don’t be afraid •Drugs, dialysis •Raised ICP •Coagulation •Manage Infections •Transplant •Palliate

Editor's Notes

  • #6 Grade 1,ii rare Grade iii 25-35% Grade iv 65-75% Cerebral oedema most common cause of death.
  • #11 In america ALFSG index used which includes patient gcs,bilrubin,inr,sr phosphorus,and sr M30 (ELISA based marker of apoptosis)..Limited use as M30 not available everywhere.Better prognostic indicator than KCC.
  • #13 Improved mortality due to orthoptic liver transplant and better critical care. Research difficult due to rare and heterogenous nature with rapidly progressive course but result from application of other research e.g from cerebral edema management has improved mortality.
  • #23 Reduces IL 17 levels in Non paracetamol ALF pts. In pcm overdose replinishes glutathione stores and detoxifies NAPQ1 highly reactive,toxic metabolite of paracetamol overdose.
  • #34 Most common cause of death-cerebral oedema.
  • #35 20_25% deaths in ALF due to intracranial hypertention and BS herniation. HE four compatible theories Cerebral vasomotor dysfunction Oedema secondary to ammonia toxicity Inflammation due to SIRS putative benzodiazepine-like molecules
  • #37 Complication rate with ICP monitor 3.8%,fatal haemorrhage 1%
  • #43 Common organisms growing klebsiella oxy, VRE, Enterococcus faecium.
  • #45 Prophylactic antibiotics for greatest risk pts as mentioned above.